Grace Therapeutics, Inc. (GRCE) Operating income 2019–2026
Grace Therapeutics, Inc. (GRCE) annual operating income history from SEC filings — each fiscal year as reported.
-$11.1MFY2026 · since FY2019: -$34.4M → -$11.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2026 | -$11.1M | +33.6% |
| FY2025 | -$16.7M | -29.8% |
| FY2024 | -$12.9M | +75.4% |
| FY2023 | -$52.2M | -234.6% |
| FY2022 | -$15.6M | +5.1% |
| FY2021 | -$16.4M | +32.8% |
| FY2020 | -$24.4M | +29.0% |
| FY2019 | -$34.4M | — |
Source: SEC XBRL filings · For reference only · Not investment advice